Sharesmagazine
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Share Price   Awards   Market Scan   Videos   Broker Notes   Director Deals   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Indices   Forward Diary   Forex Prices   Shares Magazine   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Comparison Tables   Spread Betting 
You are NOT currently logged in
 
Register now or login to post to this thread.
  • Page:
  • 1
  • 2
  • 3
  • 4

Oxford Biomedica Keeps going Up (OXB)     

apple - 10 Dec 2003 15:45

draw?scheme=Colourful&epic=OXBdraw?scheme=Colourful&size=Medium&showVodraw?scheme=Colourful&showVolume=true&stdraw?scheme=Colourful&size=Medium&showVo



Almost Day after day, this keeps going up.

What happens is there are lots of small shareholders selling out during the day who probably bought in when it was 25p due to being tipped in shares mag in July

THEN

At the end of each day there is a really BIG BUY that most people don't notice.
Usually at 16:29.

Next morning, it usually opens up 1/4p

This keeps on happening.

I finally freed up some cash this morning & bought some.
I wish that I had got in at 17p.

The big buyers obviously think that the new drugs will ge a great success.

What do you think?


It was also tipped again in October

SHARES MAGAZINE 30-10-2003

The gene therapy specialist has had a good run this year with shares rising to 28.2p in September. The company has two cancer therapies in the clinic for a range of indications as well as early-stage drugs for neurological disorders.

TroVax is a revolutionary cancer vaccine that works by delivering a gene to the cancer cell via a pox virus acting as a Trojan horse. The drug is in Phase II trials in colorectal cancer patients with the kudos of being sponsored by Cancer Research UK and trials in breast and renal cancer patients. MetXia has also received approval to enter Phase I/II trials for pancreatic cancer.

Investors should recall the high failure rate of cancer drugs such as British Biotechs Marimastat and remember that the risks are high, but Oxford Biomedica is well funded following a recent fundraising and there is still everything to play for.

http://www.wallstreetreporter.com/profiles/OxfordBioMedica.html

apple - 10 Feb 2004 18:44 - 40 of 79

Broken through 18 month high.

I suspect that 3rd March will be good news with all this activity.

oily1 - 10 Feb 2004 20:11 - 41 of 79

Yes, big momentum at the moment, Apple. I've read that a Russian Investment Bank was the big buyer today. 3rd March will be interesting. An upward price with no news - what will happen if OXB announce a big deal on one of their products, eg., TroVax ? This will go ballistic.

apple - 10 Feb 2004 20:32 - 42 of 79

Thanks for that info oily1

Wish I had more cash to put into it now.

apple - 11 Feb 2004 08:35 - 43 of 79

Up 5.2% already this morning.

oily1 - 11 Feb 2004 12:06 - 44 of 79

And there's allegedly a Far East Investor wanting a piece of the cake.

robstuff - 16 Feb 2004 10:06 - 45 of 79

A big licensing deal is just around the corner, then this share will motor.

apple - 16 Feb 2004 10:19 - 46 of 79

Small fall after last weeks peak.

I suppose this may provide another opportunity for a big buyer again at the end of the trading day.

apple - 17 Feb 2004 13:21 - 47 of 79

Making another attempt at 30p perhaps?

robstuff - 17 Feb 2004 14:10 - 48 of 79

should clear 30p soon with news of more licensing - support at 28, next move 35p

iamole - 17 Feb 2004 15:02 - 49 of 79

I have been reading this thread with interest for a while now. I bought these at 88p about 4yrs ago to see them grow to 132p before sliding with the rest of the sector. I firmly believe that this company's got something Big and the price is just beginning to recover and may reach 100p again this year. Does anyone know when the current drug trials are predicted to show results? Once a marketable product is formulated who knows what this co is worth! I'm in for the long term.

robstuff - 18 Feb 2004 10:17 - 50 of 79

I too held these from 20p to 132, sold at 67 and 92, and have been in and out a few times last yr and hold 30k - expect some newsof trials this year. up again today, may test the recent high.

robstuff - 19 Feb 2004 14:32 - 51 of 79

MMs can't reduce the price without some big buys coming in - should move above 30 tomorrow. If any news 35p.

apple - 19 Feb 2004 17:14 - 52 of 79

Closed at 29p.

When the news comes it should smash through 30p.

robstuff - 20 Feb 2004 11:04 - 53 of 79

we could see a break through 30 today, and with news 35 plus....here's hoping! The thing is with this co. any one of it's prods could be world beating, I like the developments they have with reducing tumors.

apple - 20 Feb 2004 15:01 - 54 of 79

Was this a BUY?

20/02/04 14:50 Holding(s) in Company RNS

Janus - 20 Feb 2004 15:26 - 55 of 79

Yes, they have got more as they had just over 9% previously

apple - 20 Feb 2004 20:59 - 56 of 79

Thanks Janus.

oily1 - 28 Feb 2004 18:35 - 57 of 79

One or two institutions dipping their toe into the OXB water, I hear.

Roll on Wednesday and Final Results. Should be interesting to see what AK has to say.

apple - 01 Mar 2004 14:41 - 58 of 79

Just at the level of breakout as I write this.

Looks good for wednesday

oily1 - 01 Mar 2004 14:56 - 59 of 79

Yes, we're off the blocks today, Apple - as you say, looks good for Wednesday.
  • Page:
  • 1
  • 2
  • 3
  • 4
Register now or login to post to this thread.